NCT05573815招募中不适用
An Open Label, Single-Center and Random-Selection Retrospective Pivotal Study of Clinical Decision Support System for Brain Metastasis Using Brain MR Images
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- Heuron Inc.
- 入组人数
- 558
- 试验地点
- 2
- 主要终点
- Sensitivity and false positive rates of BT-M01
研究概览
简要总结
BT-M01 is a software that has been pre-learned based on a brain metastasis detection model using brain MR images, and clinical decision support system for brain metastasis by automatically analyzing brain MR images by assisting the medical team.
The specific aims of this study are to evaluate efficacy of BT-M01 for brain metastasis compared to the sensitivity and false positive rates of radiologists group.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults over 19 years old
- •Brain MR acquired
- •Positive group: A patient diagnosed with brain metastasis after a brain MR
- •Negative group: A normal person or a patient not diagnosed with brain metastasis after a brain MR
排除标准
- •Poor or incomplete brain MR image quality
- •A patient with other pathological lesion in brain
- •A patients with a history of primary brain tumors
结局指标
主要结局
Sensitivity and false positive rates of BT-M01
时间窗: Within 4 weeks after enrollment
Sensitivity and false positive rates of BT-M01 in detection of brain metastasis based on golden standards
次要结局
- Positive predictive values of BT-M01(Within 4 weeks after enrollment)
- Sensitivity and Positive predictive values of BT-M01 by primary cancer(Within 4 weeks after enrollment)
- Dice coefficient of BT-M01(Within 4 weeks after enrollment)
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
不适用
An Evaluation of a Non-invasive Brain MonitorBrain InjuriesVasospasm, IntracranialBrain NeoplasmsHydrocephalusSubarachnoid HemorrhageNCT02775136HeadSense Medical160
招募中
不适用
Using Machine Learning and Biomarkers for Early Detection of Delayed Cerebral IschemiaIschemic StrokeHemorrhagic StrokeNCT06069973Sahlgrenska University Hospital1,500
已完成
1 期
Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain MetastasesNon-small Cell Lung CancerNCT03463525AstraZeneca4
撤回
不适用
SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial AccessBrain NeoplasmsNCT02307604European Organisation for Research and Treatment of Cancer - EORTC
进行中（未招募）
不适用
BRIANSTORM - Early Identification of Patients With Brain MetastasesMetastatic Rectal AdenocarcinomaBrain MetastasesNCT05185557Aarhus University Hospital50